HOUSE - BILL

HB 2218

Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

On General Orders in House

Bill Progress

Introduced
Committee
Committee Report
Floor Action
Opposite Chamber
Enrolled
Governor

Versions

Bill Supp. Note
As Amended by House Committee

Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

As Introduced

Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

vs. Compare
Document Reports

Amendments, Committee Reports, & Conference Committee Reports

Committee Reports 1
Committee Report
House Committee on Health and Human Services Wed, Jan 28, 2026 And the bill be passed as amended.

Legislative History

Loading…

Testimony & Minutes

House · Committee on Health and Human Services 4
Hearing Date Minutes Presenter Organization Topic PDF
Jan 26, 2026 View Jenna Moyer Revisor of Statutes HB2218 amendment
Feb 11, 2025 View Tess Bettler Compass Pathways A01 HB2218
Feb 11, 2025 View James Davis Private Citizen A02 HB2218
Feb 11, 2025 View Alexandra Blasi Kansas Board of Pharmacy A03 HB2218

Identification

Bill No. HB 2218
Chamber House
Requested By Requested by Steve Kearney on behalf of Compass Pathways

Original Sponsor

Current Sponsor

Sections Affected

Amended

K.S.A. 2024 Supp. 65-4101 and 65-4111

Effective Date

This act shall take effect and be in force from and after its publication in the statute book.
Refreshing…